Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Amphastar Pharmaceuticals (AMPH) over the last 12 years, with Q3 2025 value amounting to 0.1%.

  • Amphastar Pharmaceuticals' Return on Capital Employed fell 500.0% to 0.1% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.1%, marking a year-over-year decrease of 500.0%. This contributed to the annual value of 0.15% for FY2024, which is 700.0% down from last year.
  • As of Q3 2025, Amphastar Pharmaceuticals' Return on Capital Employed stood at 0.1%, which was down 500.0% from 0.13% recorded in Q2 2025.
  • Over the past 5 years, Amphastar Pharmaceuticals' Return on Capital Employed peaked at 0.18% during Q1 2023, and registered a low of 0.03% during Q1 2021.
  • Over the past 5 years, Amphastar Pharmaceuticals' median Return on Capital Employed value was 0.15% (recorded in 2023), while the average stood at 0.13%.
  • In the last 5 years, Amphastar Pharmaceuticals' Return on Capital Employed surged by 1100bps in 2022 and then crashed by -500bps in 2025.
  • Over the past 5 years, Amphastar Pharmaceuticals' Return on Capital Employed (Quarter) stood at 0.13% in 2021, then soared by 34bps to 0.17% in 2022, then fell by -10bps to 0.15% in 2023, then decreased by -2bps to 0.15% in 2024, then fell by -29bps to 0.1% in 2025.
  • Its Return on Capital Employed stands at 0.1% for Q3 2025, versus 0.13% for Q2 2025 and 0.14% for Q1 2025.